Clinical Trial

Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

Name: Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS) — clinical trial record (NCT07675109)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study assesses the tolerability, safety, and impact of an investigational medical device on restless legs syndrome symptoms. The IRB has established that the investigational device is non-significant risk.

Trial Details

NCT Number	NCT07675109
Lead Sponsor	Noctrix Health, Inc.
Conditions	Restless Legs Syndrome (RLS)
Enrollment	20 participants
Start Date	2026-06-08
Primary Completion	2026-12 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-30